Condition: Asthma
Interventions: Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744) low; Drug: Olodaterol (BI 1744) high; Drug: Formoterol 12 mcg; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days